OrthoPediatrics Corp. Announces Pricing of Initial Public Offering
WARSAW — OrthoPediatrics Corp. in Warsaw, an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today the pricing of its initial public offering of 4,000,000 shares of its common stock at public offering price of $13 per share. In addition, OrthoPediatrics has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of its common stock at the public offering price, less the underwriting discount. The shares were expected to begin trading on the NASDAQ Global Market on Oct. 12, under the ticker symbol “KIDS.” The offering is scheduled to close on Oct. 16, subject to customary closing conditions.
Piper Jaffray and Stifel are acting as joint book-running managers, William Blair is acting as lead manager and BTIG is acting as co-manager for the offering.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission and was declared effective on Oct. 11. The offering is being made only by means of a prospectus, copies of which may be obtained from: Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minn. 55402, via telephone at (800) 747-3924 or via email at [email protected]; or from Stifel, Nicolaus & Company Inc., Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, Calif. 94104, via telephone at (415) 364-2720 or via email at [email protected].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.